Lido Advisors, LLC Q3 2019 Filing

Filed November 12, 2019

Portfolio Value

$1.3T

Holdings

513

Report Date

Q3 2019

Filing Type

13F-HR

All Holdings (513 positions)

#StockSharesValue% PortfolioType
501
PENNEY J C CORP INC
170,000$151.0M0.01%
502
NLYEURANNALY CAP MGMT INC
15,914$144.0M0.01%
503
RTW RETAILWINDS INC
100,000$137.0M0.01%
504
RIGLUSDRIGEL PHARMACEUTICALS INC
54,071$101.0M0.01%
505
THERAPEUTICSMD INC
17,178$62.0M0.00%
506
YRIYAMANA GOLD INC
17,154$55.0M0.00%
507
WASHINGTON PRIME GROUP NEW
10,000$41.0M0.00%
508
CBL & ASSOC PPTYS INC
10,000$13.0M0.00%
509
LCTXLINEAGE CELL THERAPEUTICS IN
10,000$10.0M0.00%
510
SECOND SIGHT MED PRODS INC
12,000$10.0M0.00%
511
KELSO TECHNOLOGIES INC
10,092$7.0M0.00%
512
PROTALIX BIOTHERAPEUTICS INC
16,000$3.0M0.00%
513
CEMTREX INC
10,000$00.00%
PreviousPage 6 of 6